{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:38:26Z","timestamp":1781897906571,"version":"3.54.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["UNI-0210-00007.01.00\/23"],"award-info":[{"award-number":["UNI-0210-00007.01.00\/23"]}],"id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#382025\/2023-7"],"award-info":[{"award-number":["#382025\/2023-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12035-024-04008-8","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T03:02:47Z","timestamp":1707793367000},"page":"6754-6770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson\u2019s Disease: a New Genetic State of the Art"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6543-481X","authenticated-orcid":false,"given":"J\u00falio C\u00e9sar Claudino","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Braga Cabrera","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Rodrigues","family":"da Cunha Barreto-Vianna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulia Fernanda Meira","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Vieira","family":"de Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio S\u00e9rgio Gomes","family":"S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Lopes","family":"de Souza Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Gabriela Ponte","family":"Farias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Seimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micael Porto Portela","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor Caetano","family":"Goes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Teixeira Pinheiro","family":"Gusm\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard Lopes Ribeiro","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"issue":"1","key":"4008_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/cells12010191","volume":"12","author":"E Pradas","year":"2023","unstructured":"Pradas E, Martinez-Vicente M (2023) The consequences of GBA deficiency in the autophagy-lysosome system in PD associated with GBA. Cells 12(1):191. https:\/\/doi.org\/10.3390\/cells12010191","journal-title":"Cells"},{"issue":"714","key":"4008_CR2","doi-asserted-by":"publisher","first-page":"134544","DOI":"10.1016\/j.neulet.2019.134544","volume":"1","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Chen J, Xu C, Feng J, Li J (2020) Effects of glucocerebrosidase gene polymorphisms and mutations on the risk of PD dementia: a ambroxol meta-analysis. Neurosci Lett 1(714):134544. https:\/\/doi.org\/10.1016\/j.neulet.2019.134544","journal-title":"Neurosci Lett"},{"issue":"14","key":"4008_CR3","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.3390\/ijms22147630","volume":"22","author":"M Fais","year":"2021","unstructured":"Fais M, Dore A, Galioto M, Galleri G, Crosio C, Iaccarino C (2021) PD-related genes and lipid alteration. Int J Mol Sci 22(14):7630. https:\/\/doi.org\/10.3390\/ijms22147630","journal-title":"Int J Mol Sci"},{"key":"4008_CR4","doi-asserted-by":"publisher","first-page":"105663","DOI":"10.1016\/j.nbd.2022.105663","volume":"166","author":"ME Gegg","year":"2022","unstructured":"Gegg ME, Menozzi E, Schapira AHV (2022) Glucocerebrosidase-associated Parkinson disease: pathogenic mechanisms and potential drug treatments. Neurobiol Dis 166:105663. https:\/\/doi.org\/10.1016\/j.nbd.2022.105663","journal-title":"Neurobiol Dis"},{"issue":"5","key":"4008_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-022-00281-6","volume":"11","author":"SYY Pang","year":"2022","unstructured":"Pang SYY, Lo RCN, Ho PWL, Liu HF, Chang EES, Leung CT et al (2022) LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in PD. Transl Neurodegener 11(5):1\u201314. https:\/\/doi.org\/10.1186\/s40035-022-00281-6","journal-title":"Transl Neurodegener"},{"issue":"2","key":"4008_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14802\/jmd.19080","volume":"13","author":"JO Aasly","year":"2020","unstructured":"Aasly JO (2020) Long-term outcomes of genetic PD. J Mov Disord 13(2):81\u201396. https:\/\/doi.org\/10.14802\/jmd.19080","journal-title":"J Mov Disord"},{"key":"4008_CR7","doi-asserted-by":"publisher","unstructured":"Senkevich K, Rudakou U, Gan-Or Z (2022) New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin. Neuropharmacology 202:108822. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108822","DOI":"10.1016\/j.neuropharm.2021.108822"},{"issue":"1","key":"4008_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12929-021-00775-x","volume":"28","author":"MC Kuo","year":"2021","unstructured":"Kuo MC, Liu SC, Hsu YF, Wu RM (2021) The role of noncoding RNAs in PD: biomarkers and associations with pathogenic pathways. J Biomed Sci 28(1):78. https:\/\/doi.org\/10.1186\/s12929-021-00775-x","journal-title":"J Biomed Sci"},{"issue":"3","key":"4008_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s43587-021-00042-6","volume":"1","author":"F Kern","year":"2021","unstructured":"Kern F, Fehlmann T, Violich I, Alsop E, Hutchins E, Kahraman M et al (2021) Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during PD progression. Nat Aging 1(3):309\u2013322. https:\/\/doi.org\/10.1038\/s43587-021-00042-6","journal-title":"Nat Aging"},{"issue":"7","key":"4008_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1001\/jamaneurol.2013.1274","volume":"70","author":"LM Chahine","year":"2013","unstructured":"Chahine LM, Qiang J, Ashbridge E, Minger J, Yearout D, Horn S et al (2013) Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations. JAMA Neurol 70(7):852\u2013858. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1274","journal-title":"JAMA Neurol"},{"issue":"8","key":"4008_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/cells11081261","volume":"11","author":"L Smith","year":"2022","unstructured":"Smith L, Schapira AHV (2022) GBA variants and Parkinson disease: mechanisms and treatments. Cells 11(8):1261. https:\/\/doi.org\/10.3390\/cells11081261","journal-title":"Cells"},{"issue":"5","key":"4008_CR12","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.stemcr.2017.08.026","volume":"9","author":"J Arias-Fuenzalida","year":"2017","unstructured":"Arias-Fuenzalida J, Jarazo J, Qing X, Walter J, Gomez-Giro G, Nickels SL et al (2017) FACS-assisted CRISPR-Cas9 genome editing facilitates PD modeling. Stem Cell Reports 9(5):1423\u20131431. https:\/\/doi.org\/10.1016\/j.stemcr.2017.08.026","journal-title":"Stem Cell Reports"},{"issue":"4","key":"4008_CR13","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s11481-019-09844-3","volume":"14","author":"J Luo","year":"2019","unstructured":"Luo J, Padhi P, Jin H, Anantharam V, Zenitsky G, Wang Q, Willette AA et al (2019) Utilization of the CRISPR-Cas9 gene editing system to dissect neuroinflammatory and neuropharmacological mechanisms in PD. J Neuroimmune Pharmacol 14(4):595\u2013607. https:\/\/doi.org\/10.1007\/s11481-019-09844-3","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"4008_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40824-023-00381-y","volume":"27","author":"P Pinjala","year":"2023","unstructured":"Pinjala P, Tryphena KP, Prasad R, Khatri DK, Sun W, Singh SB et al (2023) CRISPR\/Cas9 assisted stem cell therapy in PD. Biomater Res 27(1):46. https:\/\/doi.org\/10.1186\/s40824-023-00381-y","journal-title":"Biomater Res"},{"issue":"6","key":"4008_CR15","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s10072-021-05230-1","volume":"42","author":"Q Li","year":"2021","unstructured":"Li Q, Jing Y, Lun P, Liu X, Sun P (2021) Association of gender and age at onset with glucocerebrosidase associated PD: a systematic review and meta-analysis. Neurol Sci 42(6):2261\u20132271. https:\/\/doi.org\/10.1007\/s10072-021-05230-1","journal-title":"Neurol Sci"},{"issue":"7","key":"4008_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/mds.29047","volume":"37","author":"M Filippi","year":"2022","unstructured":"Filippi M, Balestrino R, Basaia S, Agosta F (2022) Neuroimaging in glucocerebrosidase-associated parkinsonism: a systematic review. Mov Disord 37(7):1375\u20131393. https:\/\/doi.org\/10.1002\/mds.29047","journal-title":"Mov Disord"},{"key":"4008_CR17","doi-asserted-by":"publisher","first-page":"104620","DOI":"10.1016\/j.nbd.2019.104620","volume":"134","author":"SY Yang","year":"2020","unstructured":"Yang SY, Gegg M, Chau D, Schapira A (2020) Glucocerebrosidase activity, cathepsin D and monomeric \u03b1-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation. Neurobiol Dis 134:104620. https:\/\/doi.org\/10.1016\/j.nbd.2019.104620","journal-title":"Neurobiol Dis"},{"issue":"3","key":"4008_CR18","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/brain\/awab371","volume":"145","author":"C Galvagnion","year":"2022","unstructured":"Galvagnion C, Marlet FR, Cerri S, Schapira AHV, Blandini F, Di Monte DA (2022) Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation. Brain 145(3):1038\u20131051. https:\/\/doi.org\/10.1093\/brain\/awab371","journal-title":"Brain"},{"issue":"9","key":"4008_CR19","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00702-022-02531-3","volume":"129","author":"SRL Vieira","year":"2022","unstructured":"Vieira SRL, Schapira AHV (2022) Glucocerebrosidase mutations and Parkinson disease. J Neural Transm (Vienna) 129(9):1105\u20131117. https:\/\/doi.org\/10.1007\/s00702-022-02531-3","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"4008_CR20","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/mds.28616","volume":"36","author":"M Toffoli","year":"2021","unstructured":"Toffoli M, Higgins A, Lee C, Koletsi S, Chen X, Eberle M et al (2021) Intronic haplotypes in the GBA gene do not predict age at diagnosis of PD. Mov Disord 36(6):1456\u20131460. https:\/\/doi.org\/10.1002\/mds.28616","journal-title":"Mov Disord"},{"issue":"11","key":"4008_CR21","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1002\/mds.29197","volume":"37","author":"RA Ortega","year":"2022","unstructured":"Ortega RA, Bressman SB, Raymond D, Ozelius LJ, Katsnelson V, Leaver K et al (2022) Differences in sex-specific frequency of glucocerebrosidase variant carriers and familial parkinsonism. Mov Disord 37(11):2217\u20132225. https:\/\/doi.org\/10.1002\/mds.29197","journal-title":"Mov Disord"},{"issue":"1","key":"4008_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10719-021-10023-x","volume":"39","author":"KL Wallom","year":"2022","unstructured":"Wallom KL, Fern\u00e1ndez-Su\u00e1rez ME, Priestman DA, Te Vruchte D, Huebecker M, Hallett PJ et al (2022) Glycosphingolipid metabolism and its role in ageing and PD. Glycoconj J 39(1):39\u201353. https:\/\/doi.org\/10.1007\/s10719-021-10023-x","journal-title":"Glycoconj J"},{"issue":"175","key":"4008_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2021.08.230","volume":"1","author":"SRL Vieira","year":"2021","unstructured":"Vieira SRL, Schapira AHV (2021) Glucocerebrosidase mutations: a paradigm for neurodegeneration pathways. Free Radic Biol Med 1(175):42\u201355. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.08.230","journal-title":"Free Radic Biol Med"},{"issue":"52","key":"4008_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-022-00554-8","volume":"17","author":"GM Riboldi","year":"2022","unstructured":"Riboldi GM, Vialle RA, Navarro E, Udine E, Lopes KP, Humphrey J et al (2022) Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related PD. Mol Neurodegeneration 17(52):1\u201317. https:\/\/doi.org\/10.1186\/s13024-022-00554-8","journal-title":"Mol Neurodegeneration"},{"key":"4008_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.conb.2021.11.004","volume":"72","author":"I Milenkovic","year":"2022","unstructured":"Milenkovic I, Blumenreich S, Futerman AH (2022) GBA mutations, glucosylceramide and PD. Curr Opin Neurobiol 72:148\u2013154. https:\/\/doi.org\/10.1016\/j.conb.2021.11.004","journal-title":"Curr Opin Neurobiol"},{"issue":"10","key":"4008_CR26","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/mds.28667","volume":"36","author":"R Isonaka","year":"2021","unstructured":"Isonaka R, Goldstein DS, Zhu W, Yoon E, Ehrlich D, Schindler AB et al (2021) \u03b1-Synuclein deposition in sympathetic nerve fibers in genetic forms of PD. Mov Disord 36(10):2346\u20132357. https:\/\/doi.org\/10.1002\/mds.28667","journal-title":"Mov Disord"},{"key":"4008_CR27","doi-asserted-by":"publisher","first-page":"114852","DOI":"10.1016\/j.jpba.2022.114852","volume":"217","author":"SI Matsumoto","year":"2022","unstructured":"Matsumoto SI, Sato S, Otake K, Kosugi Y (2022) Highly-sensitive simultaneous quantitation of glucosylsphingosine and galactosylsphingosine in human cerebrospinal fluid by liquid chromatography\/tandem mass spectrometry. J Pharm Biomed Anal 217:114852. https:\/\/doi.org\/10.1016\/j.jpba.2022.114852","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"4008_CR28","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","volume":"29","author":"ME Gegg","year":"2020","unstructured":"Gegg ME, Verona G, Schapira AHV (2020) Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons. Hum Mol Genet 29(10):1716\u20131728. https:\/\/doi.org\/10.1093\/hmg\/ddaa085","journal-title":"Hum Mol Genet"},{"issue":"5","key":"4008_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/mds.27994","volume":"35","author":"A Sanyal","year":"2020","unstructured":"Sanyal A, DeAndrade MP, Novis HS, Lin S, Chang J, Lengacher N et al (2020) Lysosome and inflammatory defects in GBA1-mutant astrocytes are normalized by lrrk2 inhibition. Mov Disord 35(5):760\u2013773. https:\/\/doi.org\/10.1002\/mds.27994","journal-title":"Mov Disord"},{"issue":"3","key":"4008_CR30","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.3233\/JPD-212624","volume":"11","author":"A Thaler","year":"2021","unstructured":"Thaler A, Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M et al (2021) Mutations in GBA and LRRK2 are not associated with increased inflammatory markers. J Parkinsons Dis 11(3):1285\u20131296. https:\/\/doi.org\/10.3233\/JPD-212624","journal-title":"J Parkinsons Dis"},{"issue":"751","key":"4008_CR31","doi-asserted-by":"publisher","first-page":"135816","DOI":"10.1016\/j.neulet.2021.135816","volume":"23","author":"A Biswas","year":"2021","unstructured":"Biswas A, Sadhukhan D, Biswas A, Das SK, Banerjee TK, Bal PS et al (2021) Identification of GBA mutations among neurodegenerative disease patients from eastern India. Neurosci Lett 23(751):135816. https:\/\/doi.org\/10.1016\/j.neulet.2021.135816","journal-title":"Neurosci Lett"},{"issue":"421","key":"4008_CR32","doi-asserted-by":"publisher","first-page":"117291","DOI":"10.1016\/j.jns.2020.117291","volume":"15","author":"P Amami","year":"2021","unstructured":"Amami P, De Santis T, Invernizzi F, Garavaglia B, Albanese A (2021) Impulse control behavior in GBA-mutated parkinsonian patients. J Neurol Sci 15(421):117291. https:\/\/doi.org\/10.1016\/j.jns.2020.117291","journal-title":"J Neurol Sci"},{"key":"4008_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.08.008","volume":"91","author":"I Pachi","year":"2021","unstructured":"Pachi I, Koros C, Simitsi AM, Papadimitriou D, Bougea A, Prentakis A et al (2021) Apathy: an underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Parkinsonism Relat Disord 91:1\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"4008_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3233\/JPD-212657","volume":"11","author":"J Maple-Gr\u00f8dem","year":"2021","unstructured":"Maple-Gr\u00f8dem J, Paul KC, Dalen I, Ngo KJ, Wong D, Macleod AD et al (2021) Lack of association between GBA mutations and motor complications in European and American PD cohorts. J Parkinsons Dis 11(4):1569\u20131578. https:\/\/doi.org\/10.3233\/JPD-212657","journal-title":"J Parkinsons Dis"},{"issue":"10","key":"4008_CR35","doi-asserted-by":"publisher","first-page":"5347","DOI":"10.1007\/s00415-022-11181-0","volume":"269","author":"S Ghatti","year":"2022","unstructured":"Ghatti S, Yoon E, Lopez G, Ehrlich D, Horovitz SG (2022) Imaging and genetics in PD: assessment of the GBA1 mutation. J Neurol 269(10):5347\u20135355. https:\/\/doi.org\/10.1007\/s00415-022-11181-0","journal-title":"J Neurol"},{"issue":"3","key":"4008_CR36","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00415-021-10713-4","volume":"269","author":"M Leocadi","year":"2022","unstructured":"Leocadi M, Canu E, Donzuso G, Stojkovic T, Basaia S, Kresojevi\u0107 N et al (2022) Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive PD patients. J Neurol 269(3):1485\u20131500. https:\/\/doi.org\/10.1007\/s00415-021-10713-4","journal-title":"J Neurol"},{"issue":"6","key":"4008_CR37","doi-asserted-by":"publisher","first-page":"e685","DOI":"10.1212\/WNL.0000000000009989","volume":"95","author":"YE Huh","year":"2020","unstructured":"Huh YE, Chiang MSR, Locascio JJ, Liao Z, Liu G, Choudhury K et al (2020) \u03b2-Glucocerebrosidase activity in GBA-linked Parkinson disease: the type of mutation matters. Neurology 95(6):e685\u2013e696. https:\/\/doi.org\/10.1212\/WNL.0000000000009989","journal-title":"Neurology"},{"issue":"7","key":"4008_CR38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","volume":"91","author":"TB Stoker","year":"2020","unstructured":"Stoker TB, Camacho M, Winder-Rhodes S, Liu G, Scherzer CR, Foltynie T et al (2020) Impact of GBA1 variants on long-term clinical progression and mortality in incident PD. J Neurol Neurosurg Psychiatry 91(7):695\u2013702. https:\/\/doi.org\/10.1136\/jnnp-2020-322857","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4008_CR39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00702-022-02511-7","volume":"129","author":"G H\u00f6glinger","year":"2022","unstructured":"H\u00f6glinger G, Schulte C, Jost WH, Storch A, Woitalla D, Kr\u00fcger R et al (2022) GBA-associated PD: chances and obstacles for targeted treatment strategies. J Neural Transm 129:1219\u20131233. https:\/\/doi.org\/10.1007\/s00702-022-02511-7","journal-title":"J Neural Transm"},{"issue":"5","key":"4008_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/mds.28863","volume":"37","author":"D Mac\u00edas-Garc\u00eda","year":"2022","unstructured":"Mac\u00edas-Garc\u00eda D, Peri\u00f1\u00e1n MT, Mu\u00f1oz-Delgado L, Jes\u00fas S, Jimenez-Jaraba MV, Buiza-Rueda D et al (2022) Increased stroke risk in patients with PD with LRRK2 mutations. Mov Disord 37(5):225\u2013227. https:\/\/doi.org\/10.1002\/mds.28863","journal-title":"Mov Disord"},{"issue":"15","key":"4008_CR41","doi-asserted-by":"publisher","first-page":"679568","DOI":"10.3389\/fnins.2021.679568","volume":"26","author":"B Li","year":"2021","unstructured":"Li B, Zhao G, Zhou Q, Xie Y, Wang Z, Fang Z et al (2021) Gene4PD: a comprehensive genetic database of PD. Front Neurosci 26(15):679568. https:\/\/doi.org\/10.3389\/fnins.2021.679568","journal-title":"Front Neurosci"},{"issue":"6","key":"4008_CR42","doi-asserted-by":"publisher","first-page":"e0155758","DOI":"10.1371\/journal.pone.0155758","volume":"11","author":"C Shi","year":"2016","unstructured":"Shi C, Zheng Z, Wang Q, Wang C, Zhang D, Zhang M et al (2016) Exploring the effects of genetic variants on clinical profiles of PD assessed by the unified PD rating scale and the Hoehn-Yahr stage. PLoS ONE 11(6):e0155758. https:\/\/doi.org\/10.1371\/journal.pone.0155758","journal-title":"PLoS ONE"},{"issue":"1","key":"4008_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/brain\/awz350","volume":"143","author":"C Blauwendraat","year":"2020","unstructured":"Blauwendraat C, Reed X, Krohn L, Heilbron K, Bandres-Ciga S, Tan M et al (2020) Genetic modifiers of risk and age at onset in GBA associated PD and Lewy body dementia. Brain 143(1):234\u2013248. https:\/\/doi.org\/10.1093\/brain\/awz350","journal-title":"Brain"},{"issue":"4","key":"4008_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14728222.2020.1733970","volume":"24","author":"Y Chen","year":"2020","unstructured":"Chen Y, Sam R, Sharma P, Chen L, Do J, Sidransky E (2020) Glucocerebrosidase as a therapeutic target for PD. Expert Opin Ther Targets 24(4):287\u2013294. https:\/\/doi.org\/10.1080\/14728222.2020.1733970","journal-title":"Expert Opin Ther Targets"},{"issue":"D1","key":"4008_CR45","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C et al (2019) The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47(D1):D1005\u2013D1012","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4008_CR46","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/s41591-022-01796-1","volume":"28","author":"TR Rebbeck","year":"2022","unstructured":"Rebbeck TR, Mahal B, Maxwell KN, Garraway IP, Yamoah K (2022) The distinct impacts of race and genetic ancestry on health. Nat Med 28(5):890\u2013893. https:\/\/doi.org\/10.1038\/s41591-022-01796-1","journal-title":"Nat Med"},{"issue":"12","key":"4008_CR47","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1002\/mds.28225","volume":"35","author":"A Greuel","year":"2020","unstructured":"Greuel A, Trezzi JP, Glaab E, Ruppert MC, Maier F, J\u00e4ger C et al (2020) GBA variants in PD: clinical, metabolomic, and multimodal neuroimaging phenotypes. Mov Disord 35(12):2201\u20132210. https:\/\/doi.org\/10.1002\/mds.28225","journal-title":"Mov Disord"},{"key":"4008_CR48","doi-asserted-by":"publisher","first-page":"694764","DOI":"10.3389\/fneur.2021.694764","volume":"12","author":"E Menozzi","year":"2021","unstructured":"Menozzi E, Schapira AHV (2021) Exploring the genotype\u2013phenotype correlation in GBA-Parkinson disease: clinical aspects, biomarkers, and potential modifiers. Front Neurol 12:694764. https:\/\/doi.org\/10.3389\/fneur.2021.694764","journal-title":"Front Neurol"},{"issue":"18","key":"4008_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","volume":"24","author":"H Ye","year":"2023","unstructured":"Ye H, Robak LA, Yu M, Cykowski M, Shulman JM (2023) Genetics and pathogenesis of Parkinson\u2019s syndrome. Annu Rev Patho 24(18):95\u2013121. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-034145","journal-title":"Annu Rev Patho"},{"issue":"1","key":"4008_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00461-9","volume":"9","author":"S Kaiser","year":"2023","unstructured":"Kaiser S, Zhang L, Mollenhauer B, Jacob J, Longerich S, Del-Aguila J et al (2023) A proteogenomic view of PD causality and heterogeneity. NPJ Parkinsons Dis 9(1):1\u201318. https:\/\/doi.org\/10.1038\/s41531-023-00461-9","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"4008_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/ph15070811","volume":"5","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yao L, Zheng Z, Koc S, Lu G (2022) The role of non-coding RNAs in the pathogenesis of PD: recent advancement. Pharmaceuticals 5(7):811. https:\/\/doi.org\/10.3390\/ph15070811","journal-title":"Pharmaceuticals"},{"key":"4008_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fnagi.2022.819836","volume":"2022","author":"P Zhang","year":"2022","unstructured":"Zhang P, Rasheed M, Liang J, Wang C, Feng L, Chen Z (2022) Emerging potential of exosomal non-coding RNA in PD: a review. Front Aging Neurosci 2022:14. https:\/\/doi.org\/10.3389\/fnagi.2022.819836","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"4008_CR53","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s42003-022-03577-5","volume":"5","author":"K Miyoshi","year":"2022","unstructured":"Miyoshi K, Hagita H, Horiguchi T, Tanimura A, Noma T (2022) Redefining GBA gene structure unveils the ability of Cap-independent, IRES-dependent gene regulation. Commun Biolog 5(1):639. https:\/\/doi.org\/10.1038\/s42003-022-03577-5","journal-title":"Commun Biolog"},{"issue":"22","key":"4008_CR54","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","volume":"20","author":"SY Goh","year":"2019","unstructured":"Goh SY, Chao YX, Dheen ST, Tan EK, Tay SS (2019) Role of microRNAs in PD. Int J Mol Sci 20(22):5649. https:\/\/doi.org\/10.3390\/ijms20225649","journal-title":"Int J Mol Sci"},{"key":"4008_CR55","doi-asserted-by":"publisher","unstructured":"Takeuchi S, Yamamoto M, Matsumoto S, Kenjo E, Karashima M, Ikeda Y (2022) Pinpoint modification strategy for stabilization of single guide RNA. J Chromatogr B Anal Technol Biomed Life Sci 1192:123149. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123149","DOI":"10.1016\/j.jchromb.2022.123149"},{"issue":"4","key":"4008_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","volume":"40","author":"F Safari","year":"2020","unstructured":"Safari F, Hatam G, Behbahani AB, Rezai V, Barekati-Mowahed M, Petramfar P et al (2020) CRISPR system: a high-throughput toolbox for research and treatment of PD. Cell Mol Neurobiol 40(4):477\u2013493. https:\/\/doi.org\/10.1007\/s10571-019-00761-w","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"4008_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13041-020-00637-x","volume":"13","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Huang Y, Zhang P, Han C, Lu Y, Mo Z et al (2020) Characterization of a pathogenic variant in GBA for PD with mild cognitive impairment patients. Mol Brain 13(1):102. https:\/\/doi.org\/10.1186\/s13041-020-00637-x","journal-title":"Mol Brain"},{"issue":"3","key":"4008_CR58","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.26166","volume":"90","author":"J Jo","year":"2021","unstructured":"Jo J, Yang L, Tran HD, Yu W, Sun AX, Chang YY et al (2021) Lewy body-like inclusions in human midbrain organoids carrying glucocerebrosidase and \u03b1-synuclein mutations. Ann Neurol 90(3):490\u2013505. https:\/\/doi.org\/10.1002\/ana.26166","journal-title":"Ann Neurol"},{"issue":"1","key":"4008_CR59","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41467-021-22113-3","volume":"12","author":"S Kim","year":"2021","unstructured":"Kim S, Wong YC, Gao F, Krainc D (2021) Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of PD. Nat Commun 12(1):1807. https:\/\/doi.org\/10.1038\/s41467-021-22113-3","journal-title":"Nat Commun"},{"key":"4008_CR60","doi-asserted-by":"publisher","first-page":"103085","DOI":"10.1016\/j.scr.2023.103085","volume":"69","author":"A Chemla","year":"2023","unstructured":"Chemla A, Arena G, Saraiva C, Berenguer-Escuder C, Grossmann D, Gr\u00fcnewald A et al (2023) Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from PD patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1. Stem Cell Res 69:103085. https:\/\/doi.org\/10.1016\/j.scr.2023.103085","journal-title":"Stem Cell Res"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04008-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04008-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:17:11Z","timestamp":1724404631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04008-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4008"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04008-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"10 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}